Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04780009 · ClinicalTrials.gov registry record
Loupe-Based Intraoperative Fluorescence Imaging
A clinical trial of Glioblastoma Multiforme and Anaplastic Astrocytoma, sponsored by Guoqiang Yu.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04780009 is a study of Glioblastoma Multiforme and Anaplastic Astrocytoma that is actively recruiting participants, run by Guoqiang Yu. The registered enrollment target is 30 participants, below the 97-participant average among 88 other Glioblastoma Multiforme trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04780009, a study of Glioblastoma Multiforme and Anaplastic Astrocytoma, is actively recruiting participants, sponsored by Guoqiang Yu.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing techniques and technologies that allow more extensive, safe resections. This study will test a loupe-based wearable device in the clinical setting and compare its accuracy with a large operative microscope to identify tumor tissues. Postoperative histopathological analysis on tumor tissues will be used as gold standards for comparison. The outcome from this study will be a low-cost, miniaturized, easy-to-operate, loupe-based fluorescence imaging device for intraoperative guidance of brain tumor resection with the same level of accuracy as the large microscope.
Conditions Studied
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04780009
The ClinicalTrials.gov registry entry for NCT04780009 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 97-participant average among 88 other Glioblastoma Multiforme trials with a reported enrollment target (69% lower). The listed sponsor is Guoqiang Yu, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glioblastoma Multiforme appearing as the primary indexed condition, and to 0 interventions.
NCT04780009 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04780009 about?
NCT04780009 is a clinical study titled "Loupe-Based Intraoperative Fluorescence Imaging". Glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) are the most common primary malignant brain tumors. Survival of patients with these brain tumors is directly related to the extent of resection. Consequently, a great deal of effort has been directed at developing techniques and technolog...
What is the current status of trial NCT04780009?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2017-11-17. Estimated completion is 2026-06.
What conditions does trial NCT04780009 study?
This clinical trial studies the following conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma.
Who is sponsoring clinical trial NCT04780009?
This trial is sponsored by Guoqiang Yu, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04780009 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioblastoma Multiforme
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
RECRUITING · Phase 1
-
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RECRUITING · Early Phase 1
-
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
RECRUITING · Phase 1
-
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RECRUITING · Phase 1
-
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RECRUITING · Phase 2
-
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.